Revance Therapeutics

-$0.17 (-0.57%) As of 5:47 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RVNC and other ETFs, options, and stocks.

About RVNC

Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders.

CEO
Mark J. Foley
Employees
470
Headquarters
Nashville, Tennessee
Founded
1999

RVNC Key Statistics

Market Cap
2.13B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
386.95K
High Today
$30.01
Low Today
$29.33
Open Price
$30.00
Volume
166.00K
52 Week High
$34.62
52 Week Low
$22.82

RVNC Earnings

-$1.34
-$0.89
-$0.45
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure